Key Opinion Leader Webinar will focus on the oncolytic virus landscape and data that positions the Company’s novel oncolytic adenovirus (OV) platform at the forefront of development to address devastating cancers with high unmet need on November 7 at 11 am. Webcast Link
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TOVX:
